From: Balneotherapy for the treatment of post-COVID syndrome: a randomized controlled trial
Participants, No./total, No. (%) | ||
---|---|---|
Balneotherapy N = 51 | Control N = 47 | |
Sex (% female) | 45/51 (88.2) | 39/47 (83.0) |
Age, years (mean ± SD) | 47.84 ± 9.93 | 48.95 ± 8.43 |
BMI kg/m2 (mean ± SD) | 25.8 ± 5.4 | 25.54 ± 4.52 |
ICU admission (%) | 2/51 (3.9) | 1/47 (2.1) |
SARS-Cov-2 vaccination status | complete | complete |
Year of COVID-19 primoinfection (%) | ||
2020 | 36/51 (70.6) | 34/47 (72.3) |
2021 | 14/51 (27.5) | 12/47 (25.5) |
2022 | 1/51 (2) | 1/47 (2.1) |